Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03863509 · ClinicalTrials.gov registry record
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 450
- Enrollment target
NCT03863509: Completed study, sponsored by University of Wisconsin, Madison.
NCT03863509 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 450 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03863509 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 450 participants
- Enrollment target
Study Summary
This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 3 groups: exclusive e-cigarette users, exclusive cigarette smokers, and a control group of never-users. Participants can expect up to 4 weeks of study participation.
Primary Outcome
Brachial Artery Flow-Mediated Dilation is a primary cardiovascular biomarker and a measure of endothelial function that will be assessed before and after an acute exposure challenge. These are pre-challenge values. Ultrasound based changes in brachial artery diameter after a forearm cuff occlusion (250mmHg) for 5 minutes. FMD is the percent change in brachial diameter measured 60 to 90 seconds post cuff release compared to its resting diameter. A higher % dilation is an indication of better end
Interventions
- BEHAVIORAL Cigarettes
- BEHAVIORAL E-Cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2019-03-05 |
| Est. Completion | 2022-03-09 |
What the finished NCT03863509 record still lists
NCT03863509 is an observational study that tracks outcomes without assigning an intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Cigarettes is the first listed.
NCT03863509 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03863509 about?
NCT03863509 is a clinical study titled "E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease". This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 3...
What is the current status of trial NCT03863509?
This trial is currently completed. The enrollment target is 450 participants. The study started on 2019-03-05. Estimated completion is 2022-03-09.
What interventions are being tested in trial NCT03863509?
The interventions under investigation include: Cigarettes (BEHAVIORAL), E-Cigarettes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03863509?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI